Drug Type Universal CAR-T |
Synonyms |
Target |
Mechanism CD20 modulators(B-lymphocyte antigen CD20 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diffuse Large B-Cell Lymphoma | Phase 1 | - | - | |
Follicular Lymphoma | Phase 1 | - | - | |
Mantle-Cell Lymphoma | Phase 1 | - | - | |
Small Lymphocytic Lymphoma | Phase 1 | - | - |